Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Announces New Head of Board of Directors

NEW YORK, Jan 5 – Lynx Therapeutics announced Friday that Craig Taylor has been named chairman of its board of directors.

Taylor, who has been director of Lynx since March 1994, will take over from Sam Eletr. Eletr is is leaving the board but is expected to stay on as a consultant to the company.

Taylor is president of Alloy Ventures, a venture capital firm that focuses on healthcare and information technology.

He is also a director of biotechnology company Pharmacyclics and a member of the board of directors of the National Venture Capital Association. He serves on the board of advisors of the MIT/Stanford Venture Laboratory.

Lynx of Hayward, Calif., develops Megaclone, a cloning procedure designed to discover gene expression patterns and genomic variations.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.